STAT Plus: Pharmalittle: Sanofi poised to supply millions of doses of malaria drug; Roche unit apologizes for ‘Wuhan’ virus label
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Not surprisingly in these trying times, our agenda is exceedingly modest. We plan to observe a day of rest by avoiding news on the telly, at least as much as possible, and otherwise reaching out to friends and family. A nap or two is also in order. And what about you? This may be a good time to assess the success of your social distancing methods and stay-at-home policy. You could also zone out with a good book. Or call someone who, unfortunately, is feeling isolated. Well, whatever you do, remember that this, too, shall pass. And stay safe.
Sanofi (SNY) chief executive Paul Hudson says the drug maker will be able to provide millions of doses of hydroxychloroquine for patients with the illness caused by the novel coronavirus if the old malaria drug proves successful in clinical trials, Reuters reports. The company is currently manufacturing at over 93% capacity during the pandemic and made a choice to “overproduce” its drugs to ensure supplies for hospitals in Europe and the U.S. facing an unprecedented crush of patients suffering from respiratory complications.
Continue to STAT Plus to read the full story…
